Dublin, July 22, 2024 (GLOBE NEWSWIRE) — The “China Diabetes Market Report: 2024-2032” report has been added to ResearchAndMarkets.com’s offering.
The China diabetes market size reached US$ 4.7 Billion in 2023 and is forecast to reach US$ 9.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2023-2032.
China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent – making it the diabetes capital of the world.
The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.
China’s diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.
Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:
- Historical, current and future prevalence of diabetes in China
- Historical, current and future prevalence of type-1 and type-2 diabetes in China
- Historical, current and future prevalence of diabetes in the urban and rural regions in China
- Historical, current and future prevalence of diabetes among males and females in China
- Historical, current and future prevalence of diabetes among various age groups in China
- Historical, current and future diagnosis rates for diabetes in China
- Historical, current and future drug treatment rates for diabetes in China
Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:
- Performance of the Oral Antidiabetics market in China
- Performance of key classes
- Performance of key players
- Market outlook
Comprehensive situation analysis of the Chinese Insulin market and its dynamics:
- Performance of the Insulin market in China
- Performance of key classes
- Performance of key players
- Market outlook
Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:
- Performance of the diabetes diagnostics market in China
- Market Segmentation
- Key players
- Market outlook
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 131 |
| Forecast Period | 2023 – 2032 |
| Estimated Market Value (USD) in 2023 | $4.7 Billion |
| Forecasted Market Value (USD) by 2032 | $9.3 Billion |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | China |
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Diabetes Disease Overview
5.1 What is Diabetes?
5.2 Diabetes Diagnosis and Treatment
5.3 Diabetes Complications
6 China Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 China Diabetes Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Forecast
7.5 SWOT Analysis
7.6 Value Chain Analysis
7.7 Porter’s Five Forces Analysis
7.8 Market Breakup by Segment
7.8.1 China Oral Antidiabetics Market
7.8.2 China Insulin Market
8 Competitive Landscape
8.1 Competitive Structure
8.2 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/y0xnc6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
